Corrigendum to 'Future directions for the discovery of natural product-derived immunomodulating drugs: An IUPHAR positional review' [Pharmacol. Res. 177 (2022) 106076]

Autor: Cherry L. Wainwright, Mauro M. Teixeira, David L. Adelson, Eric J. Buenz, Bruno David, Keith B. Glaser, Yuka Harata-Lee, Melanie-Jayne R. Howes, Angelo A. Izzo, Pasquale Maffia, Alejandro M.S. Mayer, Claire Mazars, David J. Newman, Eimear Nic Lughadha, Adriano M.C. Pimenta, John A.A. Parra, Zhipeng Qu, Hanyuan Shen, Michael Spedding, Jean-Luc Wolfender

Publikováno v: Pharmacological Research, Vol 180, Iss , Pp 106207- (2022)

Externí odkaz: https://doaj.org/article/b215426536d141999cb70e91b0a202d1

Marine-Derived Pharmaceuticals in Clinical Trials in 2022

Autor: Alejandro MS. Mayer, Marsha Pierce, Maria Reji, Alex C. Wu, Karolina K. Jekielek, Henry Q. Le, Katelyn Howe, Maryam Butt, Sujin Seo, David J. Newman, Keith B. Glaser

Publikováno v: ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d170d566ef6ffa3e66f796fbb5eb8487
https://doi.org/10.1124/jpet.122.527010

Supplementary Figure 1 from The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway

Autor: Kathleen M. Sakamoto, Keith B. Glaser, Michael C. Heinrich, Diana Griffith, Ajia Presnell, Xiaolin Tan, Elliot M. Landaw, Joan P. Zape, Jenny E. Hernandez-Davies

Supplementary Figure 1 from The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::698a1a335f8501f11935663ce79a6014
https://doi.org/10.1158/1535-7163.22496241.v1

Data from The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway

Autor: Kathleen M. Sakamoto, Keith B. Glaser, Michael C. Heinrich, Diana Griffith, Ajia Presnell, Xiaolin Tan, Elliot M. Landaw, Joan P. Zape, Jenny E. Hernandez-Davies

The FMS-like receptor tyrosine kinase 3 (FLT3) plays an important role in controlling differentiation and proliferation of hematopoietic cells. Activating mutations in FLT3 occur in patients with acute myeloid leukemia (AML; 15%–35%), resulting in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b3aea7b1fa5cbbd1cbc65071a3339c
https://doi.org/10.1158/1535-7163.c.6535200

Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers

Autor: Kenneth Kowalkowski, Keith B. Glaser, Wayne R. Buck, Yi Yang, Rita Ciurlionis, Eric A. G. Blomme, Daniel H. Albert

Publikováno v: International Journal of Molecular Sciences, Vol 22, Iss 12629, p 12629 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 22; Issue 23; Pages: 12629

Cancer therapies targeting the vascular endothelial growth factor (VEGF) signaling pathway can lead to renal damage by disrupting the glomerular ultrafiltration apparatus. The objective of the current study was to identify sensitive biomarkers for VE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210f677cdf88bcd6d72e8a4c2ff07611
https://www.mdpi.com/1422-0067/22/23/12629